Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Laparoscopic surgery for left ovarian hemorrhage in a patient with an implantable left ventricular assist device on antithrombotic therapy and a history of right salpingo-oophorectomy open surgery for right ovarian bleeding: A case report.
Kinose Y, Shimizu A, Kakuda M, Nakagawa S, Takiuchi T, Iwamiya T, Kodama M, Kobayashi E, Ueda Y, Sawada K, Kimura T. Kinose Y, et al. Case Rep Womens Health. 2024 Nov 23;44:e00669. doi: 10.1016/j.crwh.2024.e00669. eCollection 2024 Dec. Case Rep Womens Health. 2024. PMID: 39687743 Free PMC article.
Reduced ascorbate pool and its maintenance are important determinants of O3 damage to net photosynthetic rate in Fagus crenata under elevated CO2 and soil N supply.
Yamaguchi M, Matsumoto M, Miyaguchi K, Li J, Aoki T, Ariura R, Fuse T, Zhang Y, Kinose Y, Watanabe M, Izuta T. Yamaguchi M, et al. Among authors: kinose y. Sci Total Environ. 2023 Oct 27:168102. doi: 10.1016/j.scitotenv.2023.168102. Online ahead of print. Sci Total Environ. 2023. PMID: 39491189
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and CCNE1 amplified ovarian cancer.
Xu H, Gitto SB, Ho GY, Medvedev S, Shield-Artin K, Kim H, Beard S, Kinose Y, Wang X, Barker HE, Ratnayake G, Hwang WT; Australian Ovarian Cancer Study; Hansen RJ, Strouse B, Milutinovic S, Hassig C, Wakefield MJ, Vandenberg CJ, Scott CL, Simpkins F. Xu H, et al. Among authors: kinose y. iScience. 2024 May 15;27(7):109978. doi: 10.1016/j.isci.2024.109978. eCollection 2024 Jul 19. iScience. 2024. PMID: 39021796 Free PMC article.
Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment.
Shimizu A, Sawada K, Kobayashi M, Oi Y, Oride T, Kinose Y, Kodama M, Hashimoto K, Kimura T. Shimizu A, et al. Among authors: kinose y. Cancers (Basel). 2024 Apr 12;16(8):1482. doi: 10.3390/cancers16081482. Cancers (Basel). 2024. PMID: 38672564 Free PMC article.
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer.
Kinose Y, Xu H, Kim H, Kumar S, Shan X, George E, Wang X, Medvedev S, Ferman B, Gitto SB, Whicker M, D'Andrea K, Wubbenhorst B, Hallberg D, O'Connor M, Schwartz LE, Hwang WT, Nathanson KL, Mills GB, Velculescu VE, Wang TL, Brown EJ, Drapkin R, Simpkins F. Kinose Y, et al. Res Sq [Preprint]. 2023 Sep 27:rs.3.rs-3314138. doi: 10.21203/rs.3.rs-3314138/v1. Res Sq. 2023. PMID: 37841875 Free PMC article. Preprint.
H2Bub1 loss is an early contributor to clear cell ovarian cancer progression.
Ferrari AJ, Rawat P, Rendulich HS, Annapragada AV, Kinose Y, Zhang X, Devins K, Budina A, Scharpf RB, Mitchell MA, Tanyi JL, Morgan MA, Schwartz LE, Soong TR, Velculescu VE, Drapkin R. Ferrari AJ, et al. Among authors: kinose y. JCI Insight. 2023 Jun 22;8(12):e164995. doi: 10.1172/jci.insight.164995. JCI Insight. 2023. PMID: 37345659 Free PMC article.
51 results